脓毒症中的血液滤过：我们从这里走向何方？
Hemofiltration in sepsis: where do we go from here?
作者信息
Kellum J A, Bellomo R
机构信息
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
出版信息
Crit Care. 2000;4(2):69-71. doi: 10.1186/cc659. Epub 2000 Feb 16.
Abstract
Hemofiltration as an adjunct to therapy for sepsis is now 10 years old. Despite early successes and significant theoretical advantages, the treatment remains experimental. Although feasibility has been established, efficacy has proved to be much more difficult. Clinical as well as technical difficulties remain important considerations to future studies. These issues are discussed and the brief history of hemofiltration in sepsis is reviewed.
摘要
血液滤过作为脓毒症治疗的辅助手段至今已有10年历史。尽管早期取得了成功且具有显著的理论优势，但该治疗仍处于试验阶段。虽然已证实其可行性，但疗效却困难得多。临床和技术难题仍是未来研究的重要考量因素。本文将对这些问题进行讨论，并回顾脓毒症血液滤过的简短历史。
相似文献
1
Hemofiltration in sepsis: where do we go from here?脓毒症中的血液滤过：我们从这里走向何方？
Crit Care. 2000;4(2):69-71. doi: 10.1186/cc659. Epub 2000 Feb 16.
2
Year in review 2007: Critical Care--multiple organ failure and sepsis.2007年回顾：重症监护——多器官功能衰竭与脓毒症
Crit Care. 2008;12(5):228. doi: 10.1186/cc6950. Epub 2008 Oct 14.
3
Successful management of a critically ill burn patient suffering sepsis by use of endotoxin absorption therapy (PMX).采用内毒素吸附疗法（PMX）成功治疗了一名患有败血症的重症烧伤患者。
Burns. 2004 May;30(3):276-9. doi: 10.1016/j.burns.2003.10.014.
4
Sepsis: Diagnostic and Therapeutic Challenges.脓毒症：诊断与治疗挑战
Biomed Res Int. 2016;2016:5786182. doi: 10.1155/2016/5786182. Epub 2016 Oct 17.
5
[Adsorption therapy in sepsis].[脓毒症中的吸附疗法]
Med Klin Intensivmed Notfmed. 2015 May;110(4):272-7. doi: 10.1007/s00063-014-0415-7. Epub 2014 Sep 24.
6
[Use of continuous high-volume hemofiltration in patients with sepsis and multiple organ dysfunction].[持续高容量血液滤过在脓毒症和多器官功能障碍患者中的应用]
Anesteziol Reanimatol. 2005 Mar-Apr(2):69-71.
7
[Multiple organ failure].[多器官功能衰竭]
Vestn Khir Im I I Grek. 2001;160(3):110-4.
8
Year in review in Critical Care, 2004: sepsis and multi-organ failure.《重症监护2004年年回顾：脓毒症与多器官功能衰竭》
Crit Care. 2005 Aug;9(4):409-13. doi: 10.1186/cc3728. Epub 2005 May 23.
9
Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial.连续性静脉-静脉血液滤过对严重脓毒症早期器官功能衰竭的影响：一项随机对照试验
Crit Care Med. 2009 Mar;37(3):803-10. doi: 10.1097/CCM.0b013e3181962316.
10
The evolving rationale for early enteral nutrition based on paradigms of multiple organ failure: a personal journey.基于多器官功能衰竭范式的早期肠内营养的演变原理：一段个人历程。
Nutr Clin Pract. 2009 Jun-Jul;24(3):297-304. doi: 10.1177/0884533609336604.
引用本文的文献
1
[Treatment of acute renal failure in Germany: Analysis of current practice].[德国急性肾衰竭的治疗：当前实践分析]
Med Klin Intensivmed Notfmed. 2015 May;110(4):256-63. doi: 10.1007/s00063-015-0014-2. Epub 2015 Mar 28.
2
Sepsis: clearing the blood in sepsis.脓毒症：清除脓毒症患者血液中的有害物质
Nat Rev Nephrol. 2009 Oct;5(10):559-60. doi: 10.1038/nrneph.2009.146.
3
Extracorporeal liver support: a continuing challenge.体外肝脏支持：一项持续的挑战。
Crit Care. 2007;11(1):106. doi: 10.1186/cc5143.
4
Effect of hemofiltration filter adsorption on circulating IL-6 levels in septic rats.血液滤过滤器吸附对脓毒症大鼠循环白细胞介素-6水平的影响
Crit Care. 2002 Oct;6(5):429-33. doi: 10.1186/cc1528. Epub 2002 Jun 19.
本文引用的文献
1
The immunological effects of continuous veno-venous haemodiafiltration in critically ill patients.持续静脉-静脉血液透析滤过对危重症患者的免疫效应
Crit Care. 1999;3(6):159-165. doi: 10.1186/cc370.
2
The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia.血液滤过进行强化血浆水交换对犬内毒素血症血流动力学及可溶性介质的影响
Am J Respir Crit Care Med. 2000 May;161(5):1429-36. doi: 10.1164/ajrccm.161.5.9809127.
3
Use of adsorptive mechanisms in continuous renal replacement therapies in the critically ill.吸附机制在危重症患者连续性肾脏替代治疗中的应用
Kidney Int Suppl. 1999 Nov(72):S15-9.
4
Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group.脓毒症综合征中的持续血浆滤过。脓毒症血浆滤过研究组。
Crit Care Med. 1999 Oct;27(10):2096-104. doi: 10.1097/00003246-199910000-00003.
5
Immunomodulation in sepsis: the role of hemofiltration.脓毒症中的免疫调节：血液滤过的作用
Minerva Anestesiol. 1999 Jun;65(6):410-8.
6
Diffusive vs. convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome.扩散疗法与对流疗法：对严重全身炎症反应综合征患者炎症介质的影响
Crit Care Med. 1998 Dec;26(12):1995-2000. doi: 10.1097/00003246-199812000-00027.
7
Preliminary experience with high-volume hemofiltration in human septic shock.高容量血液滤过治疗人感染性休克的初步经验。
Kidney Int Suppl. 1998 May;66:S182-5.
8
Expression of adhesion molecules and activation markers on lymphocytes and monocytes during hemodialysis.血液透析过程中淋巴细胞和单核细胞上黏附分子及活化标志物的表达
Blood Purif. 1997;15(2):61-76. doi: 10.1159/000170318.
9
Management of acute renal failure: new perspectives.急性肾衰竭的管理：新视角
Am J Kidney Dis. 1996 Sep;28(3):315-28. doi: 10.1016/s0272-6386(96)90487-4.
10
Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group.肿瘤坏死因子受体：Fc融合蛋白治疗感染性休克。可溶性肿瘤坏死因子受体脓毒症研究组。
N Engl J Med. 1996 Jun 27;334(26):1697-702. doi: 10.1056/NEJM199606273342603.
Zotero 插件